InspireMD director Raymond Cohen to resign
InspireMD, Inc. reported that board member Raymond W. Cohen, a Class III director, has tendered his resignation from the board, effective July 1, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
InspireMD, Inc. reported that board member Raymond W. Cohen, a Class III director, has tendered his resignation from the board, effective July 1, 2026. He also serves on the company’s Audit Committee and Compensation Committee.
The company states that Mr. Cohen’s resignation is for personal considerations and is not due to any disagreement with InspireMD, its board, or management on operations, policies, or practices. The Nominating and Corporate Governance Committee plans to identify and evaluate candidates to fill the board vacancy created by his departure.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective resignation date: July 1, 2026
Resignation notice date: June 26, 2026
2 metrics
Effective resignation date
July 1, 2026
Raymond W. Cohen board resignation
Resignation notice date
June 26, 2026
Date InspireMD received Raymond W. Cohen’s resignation
Key Terms
Emerging growth company, Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company Item 5.02."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Audit Committee financial
"a member of the Audit Committee of the Board"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Compensation Committee financial
"and a member of the Compensation Committee of the Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Nominating and Corporate Governance Committee financial
"The Nominating and Corporate Governance Committee of the Board intends to identify"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did InspireMD (NSPR) disclose in this 8-K filing?
InspireMD disclosed that director Raymond W. Cohen, a Class III board member, has resigned effective July 1, 2026. He currently serves on the Audit Committee and Compensation Committee, so his departure creates a board and committee vacancy the company plans to fill.
Why is InspireMD director Raymond W. Cohen resigning from the board?
The company states that Raymond W. Cohen is resigning for personal considerations. InspireMD notes his decision is not due to any disagreement with the company, its board, or management regarding operations, policies, practices, or any other company-related matters.
When will Raymond W. Cohen’s resignation from InspireMD (NSPR) take effect?
Raymond W. Cohen’s resignation from InspireMD’s board is effective July 1, 2026. Until that date, he continues serving as a Class III director and member of the Audit Committee and Compensation Committee, after which his board seat becomes vacant.
Which InspireMD board committees was Raymond W. Cohen serving on?
Raymond W. Cohen serves on InspireMD’s Audit Committee and Compensation Committee. His resignation from the board effective July 1, 2026 will also impact the composition of these committees, requiring the company to adjust membership or appoint new directors.
How does InspireMD plan to replace the resigning director on its board?
InspireMD’s Nominating and Corporate Governance Committee intends to identify and evaluate suitable candidates to fill the vacancy created by Raymond W. Cohen’s resignation. This process aims to maintain an appropriately staffed board and committee structure after his departure.
Did InspireMD report any disagreements linked to Raymond W. Cohen’s resignation?
InspireMD explicitly states that Raymond W. Cohen’s resignation is not due to any disagreement with the company, its board, or management on operations, policies, practices, or other matters, indicating an orderly transition rather than a dispute-driven departure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates